Edoardo Cignoli : AbbVie Sets Rationale for Shire Bid

Drug maker AbbVie Inc. continued its pursuit of Shire PLC Wednesday by laying out the rationale for its $46 billion takeover bid, which Shire rejected last week.



via WSJ.com: US Business http://ift.tt/1lTZCQQ